G74(P) Hereditary Angioedema Type-2, individualised long term prophylaxis using C1 esterase inhibitor

Hereditary angioedema (HAE) is an autosomal dominant disorder due to deficiency or malfunction of C1 inhibitor protein. It is characterised by recurrent angioedema episodes involving skin and mucosal surfaces. Rare attacks involving upper airway can be life threatening. Attacks are often unpredictab...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Archives of disease in childhood Ročník 101; číslo Suppl 1; s. A43
Hlavní autoři: Naseem, SR, Altamemi, S, Farsi, T
Médium: Journal Article
Jazyk:angličtina
Vydáno: London BMJ Publishing Group LTD 01.04.2016
Témata:
Prophylaxis
ISSN:0003-9888, 1468-2044
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Hereditary angioedema (HAE) is an autosomal dominant disorder due to deficiency or malfunction of C1 inhibitor protein. It is characterised by recurrent angioedema episodes involving skin and mucosal surfaces. Rare attacks involving upper airway can be life threatening. Attacks are often unpredictable in onset, progression and severity. Deaths resulting from laryngeal angioedema are well recognised. Morbidity and mortality can successfully be reduced with prophylactic C1 esterase inhibitor (C1INH). This requires careful monitoring and individualised therapy. We describe a young girl who presented with recurrent angioedema episodes. The aim is to emphasise that careful monitoring and follow up can significantly influence the quality of care and therapeutic outcomes. She presented multiple times with angioedema involving head and neck region and required multiple paediatric Intensive care unit admissions with potential risk of air way compromise. Her C1 esterase inhibitor protein level was normal with significantly low level of C1 esterase inhibitor functional protein, consistent with type 2 hereditary angioedema. She was initially started on weekly prophylactic C1INH therapy. She continued to have breakthrough angioedema episodes with reduce frequency and severity. A careful review showed that most breakthrough attacks were on day six and day seven since last C1INH therapy. Weekly prophylactic therapy was changed to every 6th day and she was closely followed up. She did not have any breakthrough angioedema episodes on every sixth day C1INH therapy for the following 8 months. C1INH therapy is expensive and may not be available in resource limited centres. We conclude that it is important to make an individualised treatment plan to improve outcome when managing a patient with HAE based on best available sources and considering the needs of the individual patient.Key words:HAE, long term prophylaxis, C1INH.6th day regimen
AbstractList Hereditary angioedema (HAE) is an autosomal dominant disorder due to deficiency or malfunction of C1 inhibitor protein. It is characterised by recurrent angioedema episodes involving skin and mucosal surfaces. Rare attacks involving upper airway can be life threatening. Attacks are often unpredictable in onset, progression and severity. Deaths resulting from laryngeal angioedema are well recognised. Morbidity and mortality can successfully be reduced with prophylactic C1 esterase inhibitor (C1INH). This requires careful monitoring and individualised therapy. We describe a young girl who presented with recurrent angioedema episodes. The aim is to emphasise that careful monitoring and follow up can significantly influence the quality of care and therapeutic outcomes. She presented multiple times with angioedema involving head and neck region and required multiple paediatric Intensive care unit admissions with potential risk of air way compromise. Her C1 esterase inhibitor protein level was normal with significantly low level of C1 esterase inhibitor functional protein, consistent with type 2 hereditary angioedema. She was initially started on weekly prophylactic C1INH therapy. She continued to have breakthrough angioedema episodes with reduce frequency and severity. A careful review showed that most breakthrough attacks were on day six and day seven since last C1INH therapy. Weekly prophylactic therapy was changed to every 6th day and she was closely followed up. She did not have any breakthrough angioedema episodes on every sixth day C1INH therapy for the following 8 months. C1INH therapy is expensive and may not be available in resource limited centres. We conclude that it is important to make an individualised treatment plan to improve outcome when managing a patient with HAE based on best available sources and considering the needs of the individual patient.Key words:HAE, long term prophylaxis, C1INH.6th day regimen
Author Altamemi, S
Naseem, SR
Farsi, T
Author_xml – sequence: 1
  givenname: SR
  surname: Naseem
  fullname: Naseem, SR
  organization: Child Health, Sultan Qaboos University Hospital, Muscat, Oman
– sequence: 2
  givenname: S
  surname: Altamemi
  fullname: Altamemi, S
  organization: Child Health, Sultan Qaboos University Hospital, Muscat, Oman
– sequence: 3
  givenname: T
  surname: Farsi
  fullname: Farsi, T
  organization: Child Health, Sultan Qaboos University Hospital, Muscat, Oman
BookMark eNqVUMtOwzAQtFCRaAv_YKkXkEjxJqnjiFNVQYtUCQ7lbPmVxlVe2C2iNy78KF-Cq3DgymlXszO7OzNCg6ZtDEITIFOAhN4Jp0ptvSptpaOYAI0SIIwm0wzO0BBSygKapgM0JIQkUc4Yu0Aj73eEQMxYMkTbZZZev9x8f36tjDPa7oU74nmzta3RphZ4c-xMFN9i22j7bvVBVNYbjau22eK9cTXuXNuVx0p8WI8P3gZ4Adj4MBPeBFlppd237hKdF6Ly5uq3jtHr48NmsYrWz8unxXwdSYgziApmckXjQhJmRF7kRTxLpJTpTCaCUaWyghogoAqV5owoI0FLBaEPbjJJ42SMJv3e8NfbIfzBd-3BNeEkB5YROiMpg8C671nKtd47U_DO2TpY50D4KVn-N1l-Spb3yfLspKa9Wta7fwl_AAHyhUY
CODEN ADCHAK
ContentType Journal Article
Copyright 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Copyright: 2016 (c) 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Copyright_xml – notice: 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
– notice: Copyright: 2016 (c) 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
DBID AAYXX
CITATION
0-V
3V.
7X7
7XB
88B
88E
88I
8A4
8AF
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ALSLI
AN0
AZQEC
BBNVY
BENPR
BHPHI
BTHHO
CCPQU
CJNVE
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9-
K9.
LK8
M0P
M0R
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEDU
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
DOI 10.1136/archdischild-2016-310863.71
DatabaseName CrossRef
ProQuest Social Sciences Premium Collection【Remote access available】
ProQuest Central (Corporate)
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Education Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
Education Periodicals
ProQuest STEM Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Social Science Premium Collection
British Nursing Database
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
BMJ Journals
ProQuest One
Education Collection
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Collection (ProQuest)
Consumer Health Database (Alumni)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Education Database (ProQuest)
Consumer Health Database (ProQuest)
ProQuest Health & Medical Collection
Medical Database ProQuest
Science Database (ProQuest)
Biological Science Database (ProQuest)
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Education
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
DatabaseTitle CrossRef
ProQuest One Education
ProQuest Central Student
ProQuest Central Essentials
ProQuest AP Science
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Social Science Premium Collection
Education Collection
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Professional Education
Biological Science Database
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Social Sciences Premium Collection
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central Basic
ProQuest Education Journals
ProQuest Science Journals
British Nursing Index with Full Text
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Education Journals (Alumni Edition)
ProQuest Central (Alumni)
DatabaseTitleList
ProQuest One Education
Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-2044
EndPage A43
ExternalDocumentID 4316569741
10_1136_archdischild_2016_310863_71
archdischild
GroupedDBID ---
..I
.55
.GJ
.VT
0-V
0R~
1CY
23M
23N
2WC
354
39C
3O-
4.4
40O
53G
5GY
5RE
5VS
6J9
7X7
7~S
88E
88I
8A4
8AF
8F7
8FE
8FH
8FI
8FJ
8GL
8R4
8R5
AAHLL
AAKAS
AAOJX
AAQOH
AAUVZ
AAWJN
AAWTL
ABAAH
ABJNI
ABKDF
ABMQD
ABOCM
ABPPZ
ABTFR
ABUWG
ABVAJ
ACGFO
ACGFS
ACGOD
ACGTL
ACHTP
ACMFJ
ACNCT
ACOAB
ACOFX
ACPRK
ACQSR
ACTZY
ADBBV
ADCEG
ADZCM
AENEX
AEUYN
AFFNX
AFKRA
AFWFF
AGQPQ
AHMBA
AHNKE
AHQMW
AIKWM
AJYBZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALSLI
AN0
AOIJS
ARALO
ASPBG
AVWKF
AZFZN
AZQEC
BAWUL
BBNVY
BCR
BENPR
BES
BHPHI
BKNYI
BLC
BLJBA
BNQBC
BOMFT
BPHCQ
BTFSW
BTHHO
BVXVI
C1A
C45
CAG
CCPQU
CJNVE
COF
CS3
CXRWF
DIK
DWQXO
E3Z
EBS
EJD
EX3
F5P
FEDTE
FYUFA
GICCO
GNUQQ
H13
HAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
IAO
IEA
IER
IHR
INH
INR
IOF
IPC
ISE
ITC
K9-
KO8
KQ8
LK8
M0P
M0R
M1P
M2P
M7P
NEJ
NTWIH
NXWIF
O9-
OHT
OK1
OVD
P2P
PCD
PHGZT
PQEDU
PQQKQ
PROAC
PSQYO
Q2X
R53
RHI
RMJ
RPM
RV8
SJN
TEORI
TR2
UAW
UHB
UKHRP
UYXKK
V24
VM9
W2D
W8F
WH7
WOW
X7M
YOC
YQY
YYQ
ZGI
ZXP
AAFWJ
AAYXX
ACQHZ
ADXHL
AERUA
AFFHD
CITATION
PHGZM
PJZUB
PPXIY
PQGLB
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
ID FETCH-LOGICAL-b1271-f8e9c62fb08ea9f9f253bbb45b3a86cc7f6e101cfc4980ceb1dbc14982887b623
IEDL.DBID M2P
ISSN 0003-9888
IngestDate Tue Oct 07 07:13:14 EDT 2025
Sat Nov 29 03:46:21 EST 2025
Thu Apr 24 23:04:49 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue Suppl 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b1271-f8e9c62fb08ea9f9f253bbb45b3a86cc7f6e101cfc4980ceb1dbc14982887b623
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
PQID 1870650481
PQPubID 2041043
ParticipantIDs proquest_journals_1870650481
crossref_primary_10_1136_archdischild_2016_310863_71
bmj_primary_10_1136_archdischild_2016_310863_71
PublicationCentury 2000
PublicationDate 20160400
2016-04-00
20160401
PublicationDateYYYYMMDD 2016-04-01
PublicationDate_xml – month: 04
  year: 2016
  text: 20160400
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Archives of disease in childhood
PublicationYear 2016
Publisher BMJ Publishing Group LTD
Publisher_xml – name: BMJ Publishing Group LTD
SSID ssj0012883
Score 2.150561
Snippet Hereditary angioedema (HAE) is an autosomal dominant disorder due to deficiency or malfunction of C1 inhibitor protein. It is characterised by recurrent...
SourceID proquest
crossref
bmj
SourceType Aggregation Database
Index Database
Publisher
StartPage A43
SubjectTerms Prophylaxis
Title G74(P) Hereditary Angioedema Type-2, individualised long term prophylaxis using C1 esterase inhibitor
URI http://adc.bmj.com/content/101/Suppl_1/A43.2.full
https://www.proquest.com/docview/1870650481
Volume 101
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Biological Science Database (ProQuest)
  customDbUrl:
  eissn: 1468-2044
  dateEnd: 20250609
  omitProxy: false
  ssIdentifier: ssj0012883
  issn: 0003-9888
  databaseCode: M7P
  dateStart: 19930101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Consumer Health Database (ProQuest)
  customDbUrl:
  eissn: 1468-2044
  dateEnd: 20250609
  omitProxy: false
  ssIdentifier: ssj0012883
  issn: 0003-9888
  databaseCode: M0R
  dateStart: 19930101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/familyhealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Education Database
  customDbUrl:
  eissn: 1468-2044
  dateEnd: 20250609
  omitProxy: false
  ssIdentifier: ssj0012883
  issn: 0003-9888
  databaseCode: M0P
  dateStart: 19930101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/education
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1468-2044
  dateEnd: 20250609
  omitProxy: false
  ssIdentifier: ssj0012883
  issn: 0003-9888
  databaseCode: 7X7
  dateStart: 19930101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1468-2044
  dateEnd: 20250609
  omitProxy: false
  ssIdentifier: ssj0012883
  issn: 0003-9888
  databaseCode: BENPR
  dateStart: 19930101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database (ProQuest)
  customDbUrl:
  eissn: 1468-2044
  dateEnd: 20250609
  omitProxy: false
  ssIdentifier: ssj0012883
  issn: 0003-9888
  databaseCode: M2P
  dateStart: 19930101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8QwFH44KuLFXdwJ6EHBOtNlmuQkKi4HZyiiMreSpMlY0Y5OR9F_70um43IRxEtJaVNCv5e35L3kA9hpctMIhZEeNREGKNSPPG5k6GVovBlDgxE4HrLbS9pus06HJ9WCW1mVVY50olPUWU_ZNfK67xJy9nSTw6dnz7JG2exqRaFRgwn0bHxb0tUKks8sgmXSHTHmcQz1pmC7YjGpuxrMvHQ7plFS_BiVEXr34YHdS1-Tj_c_7dRPNe1sz9nsf0c9BzOV10mOhmIyD2O6WICpVpVXXwR9TqPdZI9cWObOfCD67-So6OY9nelHQWys6gX7JP_cvJWXOiMPvaJLrGYnOChE60G85SWxhfRdcuITdwQD2kjsdpdLVBz9Jbg5O70-ufAqAgZP-gH1PcM0V3FgZINpwQ03QTOUUkZNGQoWK0VNrHFKK6MizhoK1X4mFYZcGMUxKtGxWobxolfoFSCGR0oYg10Dgy8I_IwRjEuBAqGEClehjj89fRoesZG60CSM0-8wpRamdAhTSv1ViEYA_a3bxgiptJquZfoF09rvj9dh2gmLK93ZgPFB_0VvwqR6HeRlfwtqtEO3YOL4tJ1c4V2rkbiraweuTZMP06fnFw
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1NT9wwEB0BraCX0kIRtNBaaiuBRLobJ5vYh6pCfHQRy2oPgLgZ27GXVJClm-XrT_EbGXsTWi5IPXDoOXGk2C9v_OKZeQBfWtw2I2lVkNoYBUoaxgG3KgoyDN6MYcCg3ofsqJN2u-z4mPcm4K6uhXFplTUneqLOBtr9I2-E_kDOdTf5cfE7cK5R7nS1ttAYw2LP3F6jZCu_727h-n6ldGf7YLMdVK4CgQppGgaWGa4TalWTGcktt7QVKaXilookS7RObWIQp9rqmLOmRi7LlEYdgdKEpSpxjQ6Q8l_ErrOYSxWkvYdTC-fcWzv0cZSW0_C5ck1p-JzPvPQV2ojMMEHyQzURfXO1-5Pq_NfjuPg4LPhYtzP7v83SG3hd7arJxvgzeAsTppiD6f0qb2AezM80Xu2tkbZzJs1HcnhLNop-PjCZOZfEafGArpP8oTgtL01GzgZFn7jIRXASEI1n8iYviSsU6JPNkPgWE7gHwGGnuUJiHL6Dw2d5yQWYKgaFWQRieayltTiUWrxB4mOsZFxJBLyWOlqCBi6yuBi3EBFeekWJ-BsWwsFCjGEh0nAJ4hoQ_zZsuUaGqOioFH9g8f7py59gpn2w3xGd3e7eB3jlgerTlJZhajS8NCvwUl-N8nL40SOfwMlzg-gehi9ADQ
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1BTxQxFH4BNBsvIooRBWmiJpgw7k5ndtoeiCHACgE2G6OEW2077ToGZnFnRflr_DpeuzMIFxIPHDzPdJLpfP1ev-l77wN42xWukyinI-ZSFCgsTiPhdBLlGLw5x4BBgw_Z0QHr9_nxsRjMwGVTC-PTKhtODESdj4z_R96Ow4Gc727SdnVaxGC79_HsZ-QdpPxJa2OnMYXIvr34jfKt2tjbxm_9jtLezpet3ah2GIh0TFkcOW6FyajTHW6VcMLRbqK1Trs6UTwzhrnMImaNM6ngHYO8lmuDmgJlCmc6800PkP4fsLRLfd_-w87n6xMM7-LbuPUJlJkteFM7qLRD_mdRhWptRGmcIRGiskg--Dr-WX3643aMvB0iQtzrzf_PM_YEHte7bbI5XR4LMGPLp9A6rPMJnoH9xNK1wXuy6x1Li4kaX5DNcliMbG5PFfEaPaLrpLguWisqm5OTUTkkPqIRnBBE6Yn6U1TEFxAMyVZMQusJ3BvgsO-FRsIcL8LXe3nJ5zBXjkr7AogTqVHO4VDq8AaFj3GKC61wIRhlkiVo4weXZ9PWIjJIsiSTNyEiPUTkFCKSxUuQNuD4t2HLDUpkTVOV_AuRl3dfXoUWYkce7PX3X8GjgNmQvbQMc5PxL7sCD835pKjGr8MiIPDtvjF0BZFMSNA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=G74%28P%29%E2%80%85Hereditary+Angioedema+Type-2%2C+individualised+long+term+prophylaxis+using+C1+esterase+inhibitor&rft.jtitle=Archives+of+disease+in+childhood&rft.au=Naseem%2C+SR&rft.au=Altamemi%2C+S&rft.au=Farsi%2C+T&rft.date=2016-04-01&rft.issn=0003-9888&rft.eissn=1468-2044&rft.volume=101&rft.issue=Suppl+1&rft.spage=A43&rft.epage=A43&rft_id=info:doi/10.1136%2Farchdischild-2016-310863.71&rft.externalDBID=n%2Fa&rft.externalDocID=10_1136_archdischild_2016_310863_71
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-9888&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-9888&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-9888&client=summon